Proteomic Portrait of Human Lymphoma Reveals Protein Molecular Fingerprint of Disease Specific Subtypes and Progression

Adams H, Liebisch P, Schmid P, Dirnhofer S, Tzankov A (2009) Diagnostic utility of the B-cell lineage markers CD20, CD79a, PAX5, and CD19 in paraffin-embedded tissues from lymphoid neoplasms. Appl Immunohistochem Mol Morphol 17(2):96–101. https://doi.org/10.1097/PAI.0b013e3181845ef4 Aebersold R, Mann M (2003) Mass spectrometry-based proteomics. Nature 422(6928):198–207. https://doi.org/10.1038/nature01511 Alsagaby SA, Khanna S, Hart KW, Pratt G, Fegan C, Pepper C, Brewis IA, Brennan P (2014) Proteomics-based strategies to identify proteins relevant to chronic lymphocytic leukemia. J Proteome Res 13(11):5051–5062. https://doi.org/10.1021/pr5002803 Anderson T, Chabner BA, Young RC, Berard CW, Garvin AJ, Simon RM, DeVita VT Jr (1982) Malignant lymphoma. 1. The histology and staging of 473 patients at the National Cancer Institute. Cancer 50(12):2699–2707. https://doi.org/10.1002/1097-0142(19821215)50:123.0.co;2-a Ansell SM, Armitage J (2005) Non-Hodgkin lymphoma: diagnosis and treatment. Mayo Clin Proc 80(8):1087–1097. https://doi.org/10.4065/80.8.1087 Arora N, Manipadam MT, Nair S (2013) Frequency and distribution of lymphoma types in a tertiary care hospital in South India: analysis of 5115 cases using the World Health Organization 2008 classification and comparison with world literature. Leuk Lymphoma 54(5):1004–1011. https://doi.org/10.3109/10428194.2012.729056 Bellei M, Sabattini E, Pesce EA, Ko YH, Kim WS, Cabrera ME, Martinez V, Dlouhy I, Paes RP, Barrese T, Vassallo J, Tarantino V, Vose J, Weisenburger D, Rüdiger T, Federico M, Pileri S (2017) Pitfalls and major issues in the histologic diagnosis of peripheral T-cell lymphomas: results of the central review of 573 cases from the T-Cell Project, an international, cooperative study. Hematol Oncol 35(4):630–636. https://doi.org/10.1002/hon.2316 Bram Ednersson S, Stenson M, Stern M, Enblad G, Fagman H, Nilsson-Ehle H, Hasselblom S, Andersson PO (2018) Expression of ribosomal and actin network proteins and immunochemotherapy resistance in diffuse large B cell lymphoma patients. Br J Haematol 181(6):770–781. https://doi.org/10.1111/bjh.15259 Cerhan JR, Ansell SM, Fredericksen ZS, Kay NE, Liebow M, Call TG, Dogan A, Cunningham JM, Wang AH, Liu-Mares W, Macon WR, Jelinek D, Witzig TE, Habermann TM, Slager SL (2007) Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma. Blood 110(13):4455–4463. https://doi.org/10.1182/blood-2007-05-088682 Chan JK, Kwong YL (2010) Common misdiagnoses in lymphomas and avoidance strategies. Lancet Oncol 11(6):579–588. https://doi.org/10.1016/s1470-2045(09)70351-1 Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, Lister TA, Vose J, Grillo-López A, Hagenbeek A, Cabanillas F, Klippensten D, Hiddemann W, Castellino R, Harris NL, Armitage JO, Carter W, Hoppe R, Canellos GP (1999) Report of an international workshop to standardize response criteria for non-Hodgkin’s lymphomas. NCI Sponsored International Working Group. J Clin Oncol 17(4):1244. https://doi.org/10.1200/jco.1999.17.4.1244 Chiang Y, Davis RG, Vishwanatha JK (1996) Altered expression of annexin II in human B-cell lymphoma cell lines. Biochim Biophys Acta 1313(3):295–301. https://doi.org/10.1016/0167-4889(96)00103-6 Cussac D, Pichereaux C, Colomba A, Capilla F, Pont F, Gaits-Iacovoni F, Lamant L, Espinos E, Burlet-Schiltz O, Monsarrat B, Delsol G, Payrastre B (2006) Proteomic analysis of anaplastic lymphoma cell lines: identification of potential tumour markers. Proteomics 6(10):3210–3222. https://doi.org/10.1002/pmic.200500647 Diamandis EP (2004) Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations. Mol Cell Proteomics 3(4):367–378. https://doi.org/10.1074/mcp.R400007-MCP200 Doerr A (2015) DIA mass spectrometry. Nat Methods 12(1):35–35. https://doi.org/10.1038/nmeth.3234 Endrizzi L, Fiorentino MV, Salvagno L, Segati R, Pappagallo GL, Fosser V (1982) Serum lactate dehydrogenase (LDH) as a prognostic index for non-Hodgkin’s lymphoma. Eur J Cancer Clin Oncol 18(10):945–949. https://doi.org/10.1016/0277-5379(82)90242-5 Ernst S, Lange C, Wilbers A, Goebeler V, Gerke V, Rescher U (2004) An annexin 1 N-terminal peptide activates leukocytes by triggering different members of the formyl peptide receptor family. J Immunol 172(12):7669–7676. https://doi.org/10.4049/jimmunol.172.12.7669 Evans LS, Hancock BW (2003) Non-Hodgkin lymphoma. Lancet 362(9378):139–146. https://doi.org/10.1016/s0140-6736(03)13868-8 Fasola G, Fanin R, Gherlinzoni F, Galieni P, Taruscio D, Frezza G, Mazza P, Pileri S, Baccarani M (1984) Serum LDH concentration in non-Hodgkin’s lymphomas. Relationship to histologic type, tumor mass, and presentation features. Acta Haematol 72(4):231–238. https://doi.org/10.1159/000206395 Fijten GH, Blijham GH (1988) Unexplained lymphadenopathy in family practice. An evaluation of the probability of malignant causes and the effectiveness of physicians’ workup. J Fam Pract 27(4):373–376. https://doi.org/10.1080/09503158808416945 Fisher SG, Fisher RI (2004) The epidemiology of non-Hodgkin’s lymphoma. Oncogene 23(38):6524–6534. https://doi.org/10.1038/sj.onc.1207843 Friedman J, Hastie T, Tibshirani R (2010) Regularization paths for generalized linear models via coordinate descent. J Stat Softw 33(1):1–22 Gastardelo TS, Cunha BR, Raposo LS, Maniglia JV, Cury PM, Lisoni FC, Tajara EH, Oliani SM (2014) Inflammation and cancer: role of annexin A1 and FPR2/ALX in proliferation and metastasis in human laryngeal squamous cell carcinoma. PLoS ONE 9(12):e111317. https://doi.org/10.1371/journal.pone.0111317 Geijtenbeek TB, Torensma R, van Vliet SJ, van Duijnhoven GC, Adema GJ, van Kooyk Y, Figdor CG (2000) Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100(5):575–585. https://doi.org/10.1016/s0092-8674(00)80693-5 Gillet LC, Navarro P, Tate S, Rost H, Selevsek N, Reiter L, Bonner R, Aebersold R (2012) Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol Cell Proteomics. https://doi.org/10.1074/mcp.O111.016717 Gulmann C, Espina V, Petricoin E 3rd, Longo DL, Santi M, Knutsen T, Raffeld M, Jaffe ES, Liotta LA, Feldman AL (2005) Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma. Clin Cancer Res 11(16):5847–5855. https://doi.org/10.1158/1078-0432.ccr-05-0637 Guo C, Liu S, Greenaway F, Sun MZ (2013) Potential role of annexin A7 in cancers. Clin Chim Acta 423:83–89. https://doi.org/10.1016/j.cca.2013.04.018 Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC et al (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84(5):1361–1392. https://doi.org/10.1182/blood.V84.5.1361.1361 Herrera AF, Crosby-Thompson A, Friedberg JW, Abel GA, Czuczman MS, Gordon LI, Kaminski MS, Millenson MM, Nademanee AP, Niland JC, Rodig SJ, Rodriguez MA, Zelenetz AD, LaCasce AS (2014) Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network. Cancer 120(13):1993–1999. https://doi.org/10.1002/cncr.28676 Law KP, Lim YP (2013) Recent advances in mass spectrometry: data independent analysis and hyper reaction monitoring. Expert Rev Proteomics 10(6):551–566. https://doi.org/10.1586/14789450.2013.858022 Legrain P, Aebersold R, Archakov A, Bairoch A, Bala K, Beretta L, Bergeron J, Borchers CH, Corthals GL, Costello CE, Deutsch EW, Domon B, Hancock W, He F, Hochstrasser D, Marko-Varga G, Salekdeh GH, Sechi S, Snyder M, Srivastava S, Uhlén M, Wu CH, Yamamoto T, Paik YK, Omenn GS (2011) The human proteome project: current state and future direction. Mol Cell Proteomics. https://doi.org/10.1074/mcp.M111.009993 Lenz G, Staudt LM (2010) Aggressive lymphomas. N Engl J Med 362(15):1417–1429. https://doi.org/10.1056/NEJMra0807082 Ma J, Chen T, Wu S, Yang C, Bai M, Shu K, Li K, Zhang G, Jin Z, He F, Hermjakob H, Zhu Y (2019) iProX: an integrated proteome resource. Nucleic Acids Res 47(D1):D1211–D1217. https://doi.org/10.1093/nar/gky869 Maiorano D, Lutzmann M, Méchali M (2006) MCM proteins and DNA replication. Current Opinion in Cell Biology 18(2):130–136. https://doi.org/10.1016/j.ceb.2006.02.006 Miguet L, Béchade G, Fornecker L, Zink E, Felden C, Gervais C, Herbrecht R, Van Dorsselaer A, Mauvieux L, Sanglier-Cianferani S (2009) Proteomic analysis of malignant B-cell derived microparticles reveals CD148 as a potentially useful antigenic biomarker for mantle cell lymphoma diagnosis. J Proteome Res 8(7):3346–3354. https://doi.org/10.1021/pr801102c Minowada J, Koshiba H, Sagawa K, Kubonishi I, Lok MS, Tatsumi E, Han T, Srivastava BI, Ohnuma T (1981) Marker profiles of human leukemia and lymphoma cell lines. J Cancer Res Clin Oncol 101(1):91–100. https://doi.org/10.1007/bf00405069 Mogami T, Yokota N, Asai-Sato M, Yamada R, Koizume S, Sakuma Y, Yoshihara M, Nakamura Y, Takano Y, Hirahara F, Miyagi Y, Miyagi E (2013) Annexin A4 is involved in proliferation, chemo-resistance and migration and invasion in ovarian clear cell adenocarcinoma cells. PLoS ONE 8(11):e80359. https://doi.org/10.1371/journal.pone.0080359 Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS (2006) Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001. Blood 107(1):265–276. https://doi.org/10.1182/blood-2005-06-2508 Morton LM, Wang SS, Cozen W, Linet MS, Chatterjee N, Davis S, Severson RK, Colt JS, Vasef MA, Rothman N, Blair A, Bernstein L, Cross AJ, De Roos AJ, Engels EA, Hein DW, Hill DA, Kelemen LE, Lim U, Lynch CF, Schenk M, Wacholder S, Ward MH, Hoar Zahm S, Chanock SJ, Cerhan JR, Hartge P (2008) Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood 112(13):5150–5160. https://doi.org/10.1182/blood-2008-01-133587 Morton LM, Slager SL, Cerhan JR, Wang SS, Vajdic CM, Skibola CF, Bracci PM, de Sanjosé S, Smedby KE, Chiu BC, Zhang Y, Mbulaiteye SM, Monnereau A, Turner JJ, Clavel J, Adami HO, Chang ET, Glimelius B, Hjalgrim H, Melbye M, Crosignani P, di Lollo S, Miligi L, Nanni O, Ramazzotti V, Rodella S, Costantini AS, Stagnaro E, Tumino R, Vindigni C, Vineis P, Becker N, Benavente Y, Boffetta P, Brennan P, Cocco P, Foretova L, Maynadié M, Nieters A, Staines A, Colt JS, Cozen W, Davis S, de Roos AJ, Hartge P, Rothman N, Severson RK, Holly EA, Call TG, Feldman AL, Habermann TM, Liebow M, Blair A, Cantor KP, Kane EV, Lightfoot T, Roman E, Smith A, Brooks-Wilson A, Connors JM, Gascoyne RD, Spinelli JJ, Armstrong BK, Kricker A, Holford TR, Lan Q, Zheng T, Orsi L, Dal Maso L, Franceschi S, La Vecchia C, Negri E, Serraino D, Bernstein L, Levine A, Friedberg JW, Kelly JL, Berndt SI, Birmann BM, Clarke CA, Flowers CR, Foran JM, Kadin ME, Paltiel O, Weisenburger DD, Linet MS, Sampson JN (2014) Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr 48:130–144. https://doi.org/10.1093/jncimonographs/lgu013 Njiri OA, Zhang X, Zhang Y, Wu B, Jiang L, Li Q, Liu W, Chen T (2020) CD209 C-type lectins promote host invasion, dissemination, and infection of Toxoplasma gondii. Front Immunol 11:656. https://doi.org/10.3389/fimmu.2020.00656 O’Neill AS, van den Berg TK, Mullen GE (2013) Sialoadhesin - a macrophage-restricted marker of immunoregulation and inflammation. Immunology 138(3):198–207. https://doi.org/10.1111/imm.12042 Obchoei S, Wongkhan S, Wongkham C, Li M, Yao Q, Chen C (2009) Cyclophilin A: potential functions and therapeutic target for human cancer. Med Sci Monit 15(11):221–232 Obermann EC, Eward KL, Dogan A, Paul EA, Loddo M, Munson P, Williams GH, Stoeber K (2005a) DNA replication licensing in peripheral B-cell lymphoma. J Pathol 205(3):318–328. https://doi.org/10.1002/path.1695 Obermann EC, Went P, Zimpfer A, Tzankov A, Wild PJ, Stoehr R, Pileri SA, Dirnhofer S (2005b) Expression of minichromosome maintenance protein 2 as a marker for proliferation and prognosis in diffuse large B-cell lymphoma: a tissue microarray and clinico-pathological analysis. BMC Cancer 5:162. https://doi.org/10.1186/1471-2407-5-162 Park S, Ko YH (2014) Peripheral T cell lymphoma in Asia. Int J Hematol 99(3):227–239. https://doi.org/10.1007/s12185-014-1520-3 Patterson AR, Endale M, Lampe K, Aksoylar HI, Flagg A, Woodgett JR, Hildeman D, Jordan MB, Singh H, Kucuk Z, Bleesing J, Hoebe K (2018) Gimap5-dependent inactivation of GSK3beta is required for CD4(+) T cell homeostasis and prevention of immune pathology. Nat Commun 9(1):430. https://doi.org/10.1038/s41467-018-02897-7 Paweletz CP, Ornstein DK, Roth MJ, Bichsel VE, Gillespie JW, Calvert VS, Vocke CD, Hewitt SM, Duray PH, Herring J, Wang QH, Hu N, Linehan WM, Taylor PR, Liotta LA, Emmert-Buck MR, Petricoin EF 3rd (2000) Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. Cancer Res 60(22):6293–6297 Peng YP, Zhu Y, Yin LD, Zhang JJ, Guo S, Fu Y, Miao Y, Wei JS (2016) The Expression and Prognostic Roles of MCMs in Pancreatic Cancer. PLoS One 11(10):e0164150. https://doi.org/10.1371/journal.pone.0164150 Pereira WO, Paiva AS, Queiroz JW, Toma L, Dietrich CP, Nader HB, Jerônimo SM (2005) Genetic polymorphism in the sulfotransferase SULT1A1 gene in cancer. Cancer Genet Cytogenet 160(1):55–60. https://doi.org/10.1016/j.cancergencyto.2004.12.005 Perretti M, D’Acquisto F (2009) Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat Rev Immunol 9(1):62–70. https://doi.org/10.1038/nri2470 Pinyol M, Salaverria I, Bea S, Fernández V, Colomo L, Campo E, Jares P (2006) Unbalanced expression of licensing DNA replication factors occurs in a subset of mantle cell lymphomas with genomic instability. Int J Cancer 119(12):2768–2774. https://doi.org/10.1002/ijc.22146 Plucinsky MC, Prorok JJ, Alhadeff JA (1986) Variant serum beta-hexosaminidase as a biochemical marker of malignancy. Cancer 58(7):1484–1487. https://doi.org/10.1002/1097-0142(19861001)58:7%3c1484::aid-cncr2820580718%3e3.0.co;2-r Poirier F, Joubert-Caron R, Labas V, Caron M (2003) Proteomic analysis of a lymphoma-derived cell line (DG75) following treatment with a demethylating drug: modification of membrane-associated proteins. Proteomics 3(6):1028–1036. https://doi.org/10.1002/pmic.200300374 Qi H, Liu S, Guo C, Wang J, Greenaway FT, Sun MZ (2015) Role of annexin A6 in cancer. Oncol Lett 10(4):1947–1952. https://doi.org/10.3892/ol.2015.3498 Qiu X, Mao Q, Tang Y, Wang L, Chawla R, Pliner HA, Trapnell C (2017) Reversed graph embedding resolves complex single-cell trajectories. Nat Methods 14(10):979–982. https://doi.org/10.1038/nmeth.4402 Ross AR, Lee PJ, Smith DL, Langridge JI, Whetton AD, Gaskell SJ (2002) Identification of proteins from two-dimensional polyacrylamide gels using a novel acid-labile surfactant. Proteomics 2(7):928–936. https://doi.org/10.1002/1615-9861(200207)2:7%3c928::AID-PROT928%3e3.0.CO;2-P Shankland KR, Armitage JO, Hancock BW (2012) Non-Hodgkin lymphoma. Lancet 380(9844):848–857. https://doi.org/10.1016/s0140-6736(12)60605-9 Shipp MA, Harrington DP, Anderson JR, Armitage JO, Bonadonna G, Brittinger G, Cabanillas F, Canellos GP, Coiffier B, Connors JM, Cowan RA, Crowther D, Dahlberg S, Engelhard M, Fisher RI, Gisselbrecht C, Horning SJ, Lepage E, Lister TA, Meerwaldt JH, Montserrat E, Nissen NI, Oken MM, Peterson BA, Tondini C, Velasquez WA, Yeap BY (1993) A predictive model for aggressive non-Hodgkin’s lymphoma. N Engl J Med 329(14):987–994. https://doi.org/10.1056/nejm199309303291402 Shomori K, Nishihara K, Tamura T, Tatebe S, Horie Y, Nosaka K, Haruki T, Hamamoto Y, Shiomi T, Nakabayashi M, Ito H (2010) Geminin Ki67 and minichromosome maintenance 2 in gastric hyperplastic polyps adenomas and intestinal-type carcinomas: pathobiological significance. Gastric Cancer 13(3):177–185. https://doi.org/10.1007/s10120-010-0558-z Siegel RL, Miller KD (2019) Cancer statistics, 2019. CA Cancer J Clin 69(1):7–34. https://doi.org/10.3322/caac.21551 Skibola CF, Curry JD, Nieters A (2007) Genetic susceptibility to lymphoma. Haematologica 92(7):960–969. https://doi.org/10.3324/haematol.11011 Steensma DP, Witzig TE (1999) Elevated serum LDH in patients with non-Hodgkin’s lymphoma: not always an ominous sign. Br J Haematol 107(2):463–464. https://doi.org/10.1046/j.1365-2141.1999.01786.x Stewart BW, and Wild CP (2014) World Cancer Report 2014. Lyon, France: International Agency for Research on Cancer. World Health Organization 630 Stewart PA, Khamis ZI, Zhau HE, Duan P, Li Q, Chung LWK, Sang QA (2017) Upregulation of minichromosome maintenance complex component 3 during epithelial-to-mesenchymal transition in human prostate cancer. Oncotarget 8(24):39209–39217. https://doi.org/10.18632/oncotarget.16835 Timmins MA, Wagner SD (2020) The new biology of PTCL-NOS and AITL: current status and future clinical impact. Br J Haematol 189(1):54–66. https://doi.org/10.1111/bjh.16428 Trapnell C, Cacchiarelli D, Grimsby J, Pokharel P, Li S, Morse M, Lennon NJ, Livak KJ, Mikkelsen TS, Rinn JL (2014) The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol 32(4):381–386. https://doi.org/10.1038/nbt.2859 Vishwanatha JK, Salazar E, Gopalakrishnan VK (2004) Absence of annexin I expression in B-cell non-Hodgkin’s lymphomas and cell lines. BMC Cancer 4:8. https://doi.org/10.1186/1471-2407-4-8 Wang J, Zhang Y, Liu X, Ma J, Liu P, Hu C, Zhang G (2014) Annexin A5 inhibits diffuse large B-cell lymphoma cell invasion and chemoresistance through phosphatidylinositol 3-kinase signaling. Oncol Rep 32(6):2557–2563. https://doi.org/10.3892/or.2014.3547 Wei B, Guo C, Liu S, Sun MZ (2015) Annexin A4 and cancer. Clin Chim Acta 447:72–78. https://doi.org/10.1016/j.cca.2015.05.016 Wu R, Nijland M, Rutgers B, Veenstra R, Langendonk M, van der Meeren LE, Kluin PM, Li G, Diepstra A, Chiu JF, van den Berg A, Visser L (2016) Proteomics based identification of proteins with deregulated expression in B cell lymphomas. PLoS ONE 11(1):e0146624. https://doi.org/10.1371/journal.pone.0146624 Yadav C, Ahmad A, D’Souza B, Agarwal A, Nandini M, Ashok Prabhu K, D’Souza V (2016) Serum lactate dehydrogenase in Non-Hodgkin’s lymphoma: a prognostic indicator. Indian J Clin Biochem 31(2):240–242. https://doi.org/10.1007/s12291-015-0511-3 Yang QP, Zhang WY, Yu JB, Zhao S, Xu H, Wang WY, Bi CF, Zuo Z, Wang XQ, Huang J, Dai L, Liu WP (2011) Subtype distribution of lymphomas in Southwest China: analysis of 6,382 cases using WHO classification in a single institution. Diagn Pathol 6:77. https://doi.org/10.1186/1746-1596-6-77 Zelenetz AD, Abramson JS, Advani RH, Andreadis CB, Byrd JC, Czuczman MS, Fayad L, Forero A, Glenn MJ, Gockerman JP, Gordon LI, Harris NL, Hoppe RT, Horwitz SM, Kaminski MS, Kim YH, Lacasce AS, Mughal TI, Nademanee A, Porcu P, Press O, Prosnitz L, Reddy N, Smith MR, Sokol L, Swinnen L, Vose JM, Wierda WG, Yahalom J, Yunus F (2010) NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin’s lymphomas. J Natl Compr Canc Netw 8(3):288–334. https://doi.org/10.6004/jnccn.2010.0021 Zhang Q, Ming J, Zhang S, Li B, Han X, Qiu X (2013) Cytokeratin positivity in anaplastic large cell lymphoma: a potential diagnostic pitfall in misdiagnosis of metastatic carcinoma. Int J Clin Exp Pathol 6(4):798–801 Zhou T, Chen Y, Hao L, Zhang Y (2006) DC-SIGN and immunoregulation. Cell Mol Immunol 3(4):279–283 Zou H, Hastie T (2005) Regularization and variable selection via the elastic net. J R Statist Soc B 67(5):301–320. https://doi.org/10.1111/j.1467-9868.2005.00503.x